Michael Jarjour is president and CEO of ODH, Inc., a health technology company providing data aggregation and analytics solutions that enable the delivery of integrated health care. He oversees ODH’s overall operations and drives strategy for its flagship product, Mentrics, a clinically-focused technology platform that integrates social determinants, behavioral, physical, pharmacy and other health data into actionable insights for the health industry. With more than 20 years of experience in pharmaceutical and healthcare technology, Michael has a proven track record of growing businesses, maximizing revenues and building highly motivated, effective management teams on a global scale.

Prior to leading ODH, Michael served as vice president, global commercialization and portfolio management at Otsuka Pharmaceutical and led the company’s global digital strategy. Before that, as president and CEO of Kinematik, he successfully grew the R&D software company. Throughout his career, he has held key leadership positions at Bristol-Myers, Pharmacia/Pfizer, Warner-Lambert/Pfizer and Wyeth with particular focus on executive management, marketing, operations, strategy and business development.

Michael is also committed to serving the tech and healthcare community. He is a venture partner and advisor at Mansa Capital, and previously served as CEO and board member of Pathonomics, a healthcare technology company developed at the University of Pennsylvania.

Michael earned his undergraduate degree in finance from Florida International University and his MBA from Rutgers University.